SCHEMBL20123930

SCHEMBL20123930

CNc1c(C)cc2ncccc2c1NC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
SYK P43405 3/20 0.40
ATAD2 Q6PL18 1/20 0.40
CCR1 P32246 1/20 0.40
CCR8 P51685 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP1B1 Q16678 1/20 0.39
NR4A2 P43354 1/20 0.39
NPC1 O15118 1/20 0.38
HSP90AA1 P07900 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NUDT1 P36639 1/20 0.37
BRD4 O60885 1/20 0.37
RIPK2 O43353 1/20 0.37
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12066598 0.85 LMNA (0.46) ALDH1A1SMN1; SMN2LMNAHTTMAPT
SCHEMBL7458840 0.79 MEN1 (0.46) ALDH1A1SMN1; SMN2HTTMAPTCYP1A2
SCHEMBL862236 0.73 NPC1 (0.54) ALDH1A1SMN1; SMN2HTTMAPTKDM4E
SCHEMBL28811930 0.73 KDM4E (0.54) ALDH1A1MAPTKDM4ESYKATAD2
SCHEMBL18743547 0.73 MAPT (0.54) ALDH1A1SMN1; SMN2LMNAHTTMAPT
SCHEMBL27883837 0.72 KDM4E (0.39) MAPTKDM4ESYKNR4A2
SCHEMBL8654916 0.72 CCR1 (0.61) ALDH1A1SMN1; SMN2LMNAHTTMAPT
SCHEMBL17173759 0.72 KDM4E (0.52) ALDH1A1SMN1; SMN2LMNAHTTMAPT
SCHEMBL20278460 0.71 MAPT (0.52) ALDH1A1SMN1; SMN2LMNAHTTMAPT
SCHEMBL15233158 0.70 SYK (0.56) ALDH1A1LMNAMAPTKDM4ESYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3318561-B1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC (US) 2021-12-22 EP disclosed
EP-2576540-B1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC (US) 2019-09-04 EP disclosed
EP-3318561-A1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF Sunovion Pharmaceuticals Inc. (US) 2018-05-09 EP disclosed